Skip to content

MRNA

Moderna, Inc.

Revenue by product

2025, ended Dec 31, 2025

Earlier:

Products by fiscal year

Products by fiscal year
Line, in USD2025202420232022202120202019201820172016
Net product sales1.8B3.1B——17.7B200M————
Covid
1.8B3.1B6.7B18.4B——————
RSV
8.0M25M————————
Other revenue126M127M177M828M796M—————
Stand-ready manufacturing revenue
80M—————————
Collaboration Arrangement, Including Arrangements With Affiliate
13M48M83M440M61M—————
Grant revenue
22M37M94M388M735M529M12M13M29M6.9M
Licensing and royalty revenue
11M42M————————
—————74M48M123M177M102M
Total1.9B3.2B6.8B19.3B18.5B803M60M135M206M108M